fda warning letter semaglutide october 2025 Societies take stand against off-brand GLP-1s over safety concerns fda compounding semaglutide warning letters

As many athletes are subject to anti-doping regulations, it is crucial to understand WADAs position on safe and compliant athlete care

For GLP-1s, common requirements include documented diet-and-exercise attempts (36 months), trials of older weight-loss medications (phentermine, orlistat, naltrexone-bupropion), or use of a preferred GLP-1 product over a non-preferred one

For PCOS patients where fertility is an issue, tirzepatide is contra-indicated until more is known about its teratogenic potential

L-Carnitine comes in several forms, each with unique benefits but which one is best for your goals

If people really are drinking less, because of GLP-1s, then cater to that